Key Findings:  Taken together, these preclinical results suggest that CB2 receptors may provide alternative therapeutic targets for the treatment of anxiety (anti-compulsive-like effect) and depression.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  United Arab Emirates
Year of Pub:  2014
Cannabinoids Studied:  AM-x Synthetic Cannabinoids
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2
DOSING DETAILS   
Study Dosing Objective:  Effective Dose
Established Protocol:  Effective dose
Dosing Regimen:  β-caryophyllene (BCP) 50mg/kg
Starting Dose:  BCP 50mg/kg
Maximum Dose:  BCP 50mg/kg
Additional Notes:  Pharmacodynamic Study Data